Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy

Resistance to targeted cancer therapies. Drug resistance can occur at

Mutation profile of non-small cell lung cancer revealed by next generation sequencing, Respiratory Research

Analysis of actionable genetic alterations in lung carcinoma from the VA National Precision Oncology Program - ScienceDirect

Genomic alterations in biliary tract cancer predict prognosis and immunotherapy outcomes

Cancer genome and tumor microenvironment: Reciprocal crosstalk shapes lung cancer plasticity

Identification of non-actionable mutations with prognostic and predictive value in patients with advanced or metastatic non-small cell lung cancer

Frontiers Epigenetic Alterations and Inflammation as Emerging Use for the Advancement of Treatment in Non-Small Cell Lung Cancer

Effect of the most common EGFR mutations in NSCLC (Non-small-cell lung

Co-occurring genomic alterations and immunotherapy efficacy in NSCLC

Cells, Free Full-Text

Current Oncology, Free Full-Text